Found 1887 clinical trials
A Study of ERAS-007 in Patients With Advanced or Metastatic Solid Tumors
dose and schedule of ERAS-007 monotherapy. To evaluate antitumor activity of ERAS-007 in various solid tumors.
- 0 views
- 17 Jul, 2021
- 6 locations
Phase I of Eribulin and Oral Irinotecan for Relapsed or Refractory Solid Tumors
This Phase I trial will establish the recommended phase II dose of eribulin in combination with fixed doses of oral irinotecan in adolescents and young adults with relapsed or refractory solid
- 2 views
- 08 Nov, 2020
- 1 location
Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors
This is a first-in-human (FIH), multicenter, open-label, uncontrolled, Phase 1/2a study with dose escalation in patients with advanced solid tumors (Part 1) and cohorts of up to 15 patients per
- 0 views
- 10 May, 2022
- 1 location
A Phase 1 Study to Evaluate JS019 in Advanced Solid Tumors or Lymphomas
This is a phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of JS019 as monotherapy in patients with advanced malignant solid tumors
- 0 views
- 27 May, 2022
- 1 location
A Phase I Study of BPI-16350 in Patients With Advanced Solid Tumor
This was an open-label Phase I study. The primary objective of the study was to assess safety, tolerability, efficacy, and pharmacokinetic characteristics of BPI-16350 in different dose groups.
- 0 views
- 08 Jul, 2022
- 1 location
A Phase 1 Study of BPI-28592 in Subjects With Advanced Solid Tumors
This is an open-labe Phase I study of BPI-28592 for the treatment of patients with solid tumors
- 0 views
- 19 Apr, 2022
Phase 1 Trial of ION537 in Patients With Molecularly Selected Advanced Solid Tumors
patients with advanced solid tumors.
- 6 views
- 21 Oct, 2022
- 1 location
Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors
activity profile of the RP2D of OBI-999 in patients with advanced solid tumors.
- 0 views
- 04 Oct, 2022
- 4 locations
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
recurrent solid tumors or metastatic solid tumors where curative or standard treatment options have been exhausted
- 0 views
- 04 Oct, 2022
- 1 location
Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors
This is a Phase 1, open-label, multicenter, dose-escalation/dose-expansion study of YBL-006, in participants with Advanced Solid Tumors. This multicenter study will be conducted in approximately
- 0 views
- 07 Oct, 2021
- 8 locations